top of page
AMTH_Logo(2022)_Horizontal_Full Colour.png

Maximize Business Potential and
Increase Revenue

With Focused ESWT

(Extracorporeal Shock Wave Therapy)

In Athletic Therapy, Rehabilitation

and Musculoskeletal conditions

Anchor 1
Anchor 3

Partnership Scenarios 

Conventional Distributor Model 

Advanced MedTech is the producer and takes on the other aspects such as branding, marketing and local registration, while partners are only required to sell the products. 

Advanced MedTech believes in teamwork and flexibility, and we offer customizable partnership scenarios. 

OEM Model 

Advanced MedTech is the producer and leaves the other aspects, such as branding, marketing, and local registration, to the partners.

Advanced MedTech is open to the partnership model that will work best for you. Our vision is to be one of the world’s best suppliers of medical solutions, and we welcome like-minded organizations who want to be a part of this journey with us. 

For more enquiries, please feel free to reach out to our team at to discuss how we can help you increase your sales and add value to your customers through

our products.

INTRO copy,.jpg

Grow your business.

Increase your revenue.

Did you know that statistics from WHO show that approximately 1.71 billion people suffer from musculoskeletal (MSK) conditions worldwide, establishing itself as the leading contributor to disability globally?¹

Based on studies conducted on the market for shock wave therapy, global shock wave sales are expected to reach USD$697.55M by 2026.²

Approximately 1.71billion

people suffer from musculoskeletal conditions worldwide

By 2026, global shock wave

sales are expected to reach



Collaborating with a

global leader in


Advanced MedTech is a global medical technology leader with a core focus in urology devices and contract manufacturing services. The Group serves millions of patients and physicians in 100 countries worldwide and has a reported USD$280M in revenue during the 2022 fiscal year, which ended in 31 March 2022.³ Advanced MedTech makes strategic investments in disruptive medical technology companies, strengthening its portfolio of healthcare solutions for customers around the world. Advanced MedTech is a wholly owned subsidiary of Temasek and has recently acquired WIKKON, a high and new technology enterprise with medical device research, engineering and manufacturing capabilities. Advanced MedTech also offers low intensity shock wave treatment options in the form of ESWT (extracorporeal shock wave therapy).

Advanced MedTech offers two devices for ESWT treatment:

Dornier Aries 2 



Dornier Aries 2 


Why treat with ESWT

ESWT is a safe and non-invasive procedure that introduces shock waves through the skin into the injured part of the body, delivering effective therapeutic results. ESWT has been proven effective in the treatment of certain injuries over the last two decades by enhancing healing through revascularization and tissue stimulation, allowing for a treatment that boasts minimal complications, great pain control and effective function recovery.⁴


Dornier Aries 2 

Dornier Aries 2 is a 100% natural, drug-free treatment device that stimulates the healing of problematic tissue, addresses pain, and supports patient tissue recovery using non-invasive methods. Being one system with multiple solutions, Dornier Aries 2 is clinically proven to treat a wide range of indications, ranging from urological issues to musculoskeletal conditions and even chronic pelvic pain syndrome.⁵ ⁻ ⁶ Backed by German engineering, Dornier Aries 2 stands out from its competitors with consistent output of shock waves throughout the device’s lifespan and a superb durability of 2,000,000 shocks, plus its unique features: the SmartFocus and KoolShield technologies. 

Screen Shot 2023-02-06 at 7.32.35 PM.png


New and improved way to change specifications of treatment plans



Active protection and cooling of

the EMSE

(electromagnetic shock wave emitter)

Anchor 4


HK.SWT-300 is a clinically proven⁷ focused ESWT device that stands out in the field. It is used to treat a comprehensive range of orthopedic, sports and MSK conditions such as ligament/tendon injuries and tennis elbow.


Unique product features include


Compact device with an intuitive user interface and “plug and play” capability make it a perfect fit for hospitals, small healthcare establishments, or even at home


Each HK.SWT-300 comes equipped with a well-designed trolley that allows for easy and convenient moving of the device as well as storage space for accessories


Large LCD screen offers easy viewing of the screen from a distance


Articulated arm with flexible joints allows for hands-free easy movement during treatment and access to hard-to-reach areas 


Near-zero start-up time


No gel pads or consumables required

HK.SWT-300 is a fuss-free, convenient device that is very easy to operate and requires no prior preparation. 

Maintenance of the product is simple, and we recommend a regular change of applicator head to maintain operational efficiency. 



1. Musculoskeletal health. (2022, July 14). Retrieved November 30, 2022, from

2. Custom-Global Extracorporeal Shock Wave Therapy Device Professional. Survey Report 2021, Forecast to 2026 (2021). Market Research.

3. Daga, A., & Ngui, Y. (2022, November 14). Exclusive: Temasek considers sale of Advanced Medtech, likely valued at about $1 bln - sources. Reuters. Retrieved January 12,

    2023, from

4. Auersperg, V., & Trieb, K. (2020). Extracorporeal shock wave therapy: an update. EFORT Open Reviews, 5(10), 584-592.

5. Porst, H. (2021). Review of the current status of low intensity extracorporeal shockwave therapy (Li-ESWT) in erectile dysfunction (ED), peyronie’s disease (pd), and sexual

    rehabilitation after radical prostatectomy with special focus on technical aspects of the different marketed ESWT devices including personal experiences in 350 patients.

    Sexual Medicine Reviews, 9(1), 93-122.

6. Mykoniatis, I., Kalyvianakis, D., Zilotis, F., Kapoteli, P., Fournaraki, A., Poulios, E., & Hatzichristou, D. (2021). Evaluation of a low-intensity shockwave therapy for chronic

     prostatitis type IIIb/chronic pelvic pain syndrome: a double-blind randomized sham-controlled clinical trial. Prostate Cancer and Prostatic Diseases, 24(2), 370-379.

7. Clinical trials performed in China. Data on file, available upon request.

bottom of page